{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:11:58Z","timestamp":1791231118916,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:00:00Z","timestamp":1730073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:00:00Z","timestamp":1730073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Arcutis Biotherapeutics, Inc."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1007\/s13555-024-01288-9","type":"journal-article","created":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T10:12:57Z","timestamp":1730110377000},"page":"3083-3095","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Patient and Healthcare Provider Perspectives on Disease Burden of Seborrheic Dermatitis in the United States: Results from a National Survey"],"prefix":"10.1007","volume":"14","author":[{"given":"Meredith T.","family":"Polaskey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshi","family":"Aldredge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candrice","family":"Heath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moises","family":"Acevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa S.","family":"Seal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Zirwas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6510-399X","authenticated-orcid":false,"given":"Raj","family":"Chovatiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,28]]},"reference":[{"issue":"9","key":"1288_CR1","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1111\/exd.14006","volume":"28","author":"TC Wikramanayake","year":"2019","unstructured":"Wikramanayake TC, Borda LJ, Miteva M, Paus R. Seborrheic dermatitis\u2014Looking beyond Malassezia. Exp Dermatol. 2019;28(9):991\u20131001.","journal-title":"Exp Dermatol"},{"issue":"6","key":"1288_CR2","first-page":"348","volume":"35","author":"T Berk","year":"2010","unstructured":"Berk T, Scheinfeld N. Seborrheic dermatitis. P T. 2010;35(6):348\u201352.","journal-title":"P T"},{"key":"1288_CR3","doi-asserted-by":"publisher","unstructured":"Borda LJ, Wikramanayake TC. Seborrheic dermatitis and dandruff: a comprehensive review. J Clin Investig Dermatol. 2015;3(2). https:\/\/doi.org\/10.13188\/2373-1044.1000019.","DOI":"10.13188\/2373-1044.1000019"},{"issue":"4","key":"1288_CR4","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1159\/000444682","volume":"1","author":"WK Cheong","year":"2016","unstructured":"Cheong WK, Yeung CK, Torsekar RG, et al. Treatment of seborrhoeic dermatitis in Asia: a consensus guide. Skin Appendage Disord. 2016;1(4):187\u201396.","journal-title":"Skin Appendage Disord"},{"issue":"4","key":"1288_CR5","first-page":"466","volume":"11","author":"SA Davis","year":"2012","unstructured":"Davis SA, Narahari S, Feldman SR, Huang W, Pichardo-Geisinger RO, McMichael AJ. Top dermatologic conditions in patients of color: an analysis of nationally representative data. J Drugs Dermatol. 2012;11(4):466\u201373.","journal-title":"J Drugs Dermatol"},{"issue":"1","key":"1288_CR6","first-page":"24","volume":"18","author":"M Elgash","year":"2019","unstructured":"Elgash M, Dlova N, Ogunleye T, Taylor SC. Seborrheic dermatitis in skin of color: clinical considerations. J Drugs Dermatol. 2019;18(1):24\u20137.","journal-title":"J Drugs Dermatol"},{"issue":"5","key":"1288_CR7","first-page":"1143","volume":"315","author":"A Buja","year":"2023","unstructured":"Buja A, Miatton A, Cozzolino C, et al. The global, regional, and national burden of seborrheic dermatitis: results and insights from the Global Burden of Disease 2019 Study. Arch Dermatol Res. 2023;315(5):1143\u20139.","journal-title":"Arch Dermatol Res"},{"issue":"4","key":"1288_CR8","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/bjd.18307","volume":"181","author":"YMF Andersen","year":"2019","unstructured":"Andersen YMF, Egeberg A. Seborrhoeic dermatitis \u2013 understood or understudied? Br J Dermatol. 2019;181(4):659.","journal-title":"Br J Dermatol"},{"issue":"5","key":"1288_CR9","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1001\/jamadermatol.2016.5538","volume":"153","author":"C Karimkhani","year":"2017","unstructured":"Karimkhani C, Dellavalle RP, Coffeng LE, et al. Global skin disease morbidity and mortality: an update from the Global Burden of Disease Study 2013. JAMA Dermatol. 2017;153(5):406\u201312.","journal-title":"JAMA Dermatol"},{"key":"1288_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.861053","volume":"12","author":"Y Xue","year":"2022","unstructured":"Xue Y, Bao W, Zhou J, et al. Global burden, incidence and disability-adjusted life-years for dermatitis: a systematic analysis combined with socioeconomic development status, 1990\u20132019. Front Cell Infect Microbiol. 2022;12: 861053.","journal-title":"Front Cell Infect Microbiol"},{"issue":"5","key":"1288_CR11","doi-asserted-by":"publisher","first-page":"519","DOI":"10.4103\/0019-5154.164410","volume":"60","author":"M Araya","year":"2015","unstructured":"Araya M, Kulthanan K, Jiamton S. Clinical characteristics and quality of life of seborrheic dermatitis patients in a tropical country. Indian J Dermatol. 2015;60(5):519.","journal-title":"Indian J Dermatol"},{"key":"1288_CR12","doi-asserted-by":"crossref","unstructured":"Szepietowski JC, Reich A, Wesolowska-Szepietowska E, Baran E, National Quality of Life in Dermatology Group. Quality of life in patients suffering from seborrheic dermatitis: influence of age, gender and education level. Mycoses. 2009;52(4):357\u201363.","DOI":"10.1111\/j.1439-0507.2008.01624.x"},{"issue":"4","key":"1288_CR13","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s40257-013-0019-7","volume":"14","author":"A C\u00f6mert","year":"2013","unstructured":"C\u00f6mert A, Akbas B, Kilic EZ, et al. Psychiatric comorbidities and alexithymia in patients with seborrheic dermatitis: a questionnaire study in Turkey. Am J Clin Dermatol. 2013;14(4):335\u201342.","journal-title":"Am J Clin Dermatol"},{"issue":"3","key":"1288_CR14","doi-asserted-by":"publisher","first-page":"312","DOI":"10.2340\/00015555-1920","volume":"95","author":"E P\u00e4rna","year":"2015","unstructured":"P\u00e4rna E, Aluoja A, Kingo K. Quality of life and emotional state in chronic skin disease. Acta Derm Venereol. 2015;95(3):312\u20136.","journal-title":"Acta Derm Venereol"},{"issue":"6","key":"1288_CR15","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1007\/s13555-021-00617-6","volume":"11","author":"PV Chernyshov","year":"2021","unstructured":"Chernyshov PV, Vozianova SV, Chubar OV. Quality of life of infants, toddlers and preschoolers with seborrhoeic, allergic contact and atopic dermatitis before and during COVID-19 pandemic. Dermatol Ther (Heidelb). 2021;11(6):2017\u201326.","journal-title":"Dermatol Ther (Heidelb)"},{"key":"1288_CR16","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/s12955-020-01558-y","volume":"18","author":"M Xuan","year":"2020","unstructured":"Xuan M, Lu C, He Z. Clinical characteristics and quality of life in seborrheic dermatitis patients: a cross-sectional study in China. Health Qual Life Outcomes. 2020;18:308.","journal-title":"Health Qual Life Outcomes"},{"issue":"6","key":"1288_CR17","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s40257-017-0284-y","volume":"18","author":"W Wei","year":"2017","unstructured":"Wei W, Anderson P, Gadkari A, et al. Discordance between physician- and patient-reported disease severity in adults with atopic dermatitis: a US cross-sectional survey. Am J Clin Dermatol. 2017;18(6):825\u201335.","journal-title":"Am J Clin Dermatol"},{"issue":"4","key":"1288_CR18","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1001\/jamadermatol.2020.5844","volume":"157","author":"E Carr","year":"2021","unstructured":"Carr E, Mahil SK, Brailean A, et al. Association of patient mental health status with the level of agreement between patient and physician ratings of psoriasis severity. JAMA Dermatol. 2021;157(4):413\u201320.","journal-title":"JAMA Dermatol"},{"issue":"3","key":"1288_CR19","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3109\/09546634.2012.687089","volume":"25","author":"RA Bacon","year":"2014","unstructured":"Bacon RA, Mizoguchi H, Schwartz JR. Assessing therapeutic effectiveness of scalp treatments for dandruff and seborrheic dermatitis, part 1: a reliable and relevant method based on the Adherent Scalp Flaking Score (ASFS). J Dermatolog Treat. 2014;25(3):232\u20136.","journal-title":"J Dermatolog Treat"},{"issue":"1","key":"1288_CR20","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1365-4632.2004.02123.x","volume":"43","author":"V Baysal","year":"2004","unstructured":"Baysal V, Yildirim M, Ozcanli C, Ceyhan AM. Itraconazole in the treatment of seborrheic dermatitis: a new treatment modality. Int J Dermatol. 2004;43(1):63\u20136.","journal-title":"Int J Dermatol"},{"issue":"11","key":"1288_CR21","volume":"14","author":"SG Parasramani","year":"2022","unstructured":"Parasramani SG, Vishwanath V, Ghia D, Gandhi MR, Dhoot D, Barkate H. Prospective, open-label, multi-centre, randomized study to compare the effectiveness, safety, and tolerability of Lulican\u2122 shampoo versus ketoconazole shampoo in Indian adult patients with mild to moderate scalp seborrheic dermatitis (LEAD study). Cureus. 2022;14(11):e32035.","journal-title":"Cureus"},{"issue":"7","key":"1288_CR22","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1111\/j.1365-2230.2011.04120.x","volume":"36","author":"C Pi\u00e9rard-Franchimont","year":"2011","unstructured":"Pi\u00e9rard-Franchimont C, Quatresooz P, Pi\u00e9rard GE. Specular light reflectance of flakes in seborrhoeic dermatitis of the scalp: a pilot study. Clin Exp Dermatol. 2011;36(7):793\u20136.","journal-title":"Clin Exp Dermatol"},{"issue":"11","key":"1288_CR23","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1111\/jocd.15804","volume":"22","author":"F Zhang","year":"2023","unstructured":"Zhang F, Li Y, Ren W, Li S. Establishment of clinical evaluation criteria for scalp seborrheic dermatitis. J Cosmet Dermatol. 2023;22(11):3042\u20136.","journal-title":"J Cosmet Dermatol"},{"issue":"3","key":"1288_CR24","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1111\/pde.14958","volume":"39","author":"LC Hollins","year":"2022","unstructured":"Hollins LC, Butt M, Hong J, Taylor SC. Research in brief: survey of hair care practices in various ethnic and racial pediatric populations. Pediatr Dermatol. 2022;39(3):494\u20136.","journal-title":"Pediatr Dermatol"},{"issue":"2","key":"1288_CR25","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.jaad.2010.05.037","volume":"64","author":"D Rucker Wright","year":"2011","unstructured":"Rucker Wright D, Gathers R, Kapke A, Johnson D, Joseph CLM. Hair care practices and their association with scalp and hair disorders in African American girls. J Am Acad Dermatol. 2011;64(2):253\u201362.","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"1288_CR26","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1111\/jdv.19913","volume":"38","author":"C Zeidler","year":"2024","unstructured":"Zeidler C, Kupfer J, Dalgard FJ, et al. Dermatological patients with itch report more stress, stigmatization experience, anxiety and depression compared to patients without itch: results from a European multi-centre study. J Eur Acad Dermatol Venereol. 2024;38(8):1649\u201361.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"1288_CR27","doi-asserted-by":"publisher","DOI":"10.5826\/dpc.1301a29","volume":"13","author":"Y Ozcan","year":"2023","unstructured":"Ozcan Y, Sungur MA, Ozcan BY, Eyup Y, Ozlu E. The psychosocial impact of chronic facial dermatoses in adults. Dermatol Pract Concept. 2023;13(1):e2023029.","journal-title":"Dermatol Pract Concept"},{"issue":"3","key":"1288_CR28","doi-asserted-by":"publisher","first-page":"151","DOI":"10.5336\/dermato.2022-90363","volume":"32","author":"H G\u00fcder","year":"2022","unstructured":"G\u00fcder H, G\u00fcder S, Ta\u015flidere N. Social media usage habits and treatment-seeking of patients with seborrheic dermatitis: a cross-sectional study. T\u00fcrkiye Klinikleri Dermatoloji Dergisi. 2022;32(3):151\u20136.","journal-title":"T\u00fcrkiye Klinikleri Dermatoloji Dergisi"},{"issue":"10","key":"1288_CR29","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1007\/s00403-023-02681-8","volume":"315","author":"S Fakhraie","year":"2023","unstructured":"Fakhraie S, Erickson T, Chovatiya R. Evaluation of a patient education platform for seborrheic dermatitis. Arch Dermatol Res. 2023;315(10):2927\u201330.","journal-title":"Arch Dermatol Res"},{"issue":"6","key":"1288_CR30","first-page":"323","volume":"95","author":"JA Wolf","year":"2015","unstructured":"Wolf JA, Moreau JF, Patton TJ, Winger DG, Ferris LK. Prevalence and impact of health-related internet and smartphone use among dermatology patients. Cutis. 2015;95(6):323\u20138.","journal-title":"Cutis"},{"issue":"2","key":"1288_CR31","doi-asserted-by":"publisher","first-page":"167","DOI":"10.4103\/mjdrdypu.mjdrdypu_123_21","volume":"16","author":"A Saxena","year":"2023","unstructured":"Saxena A, Dey V, Srivastava P, Hemnani S, Kushwaha S, Sharma S. Treatment-seeking behavior of patients attending department of dermatology in a tertiary care hospital and their impact on disease. Medical Journal of Dr D Y Patil Vidyapeeth. 2023;16(2):167\u201372.","journal-title":"Medical Journal of Dr D Y Patil Vidyapeeth"},{"issue":"2","key":"1288_CR32","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3906\/sag-1406-51","volume":"46","author":"Y Ba\u015f","year":"2016","unstructured":"Ba\u015f Y, Seckin HY, Kalkan G, et al. Prevalence and related factors of psoriasis and seborrheic dermatitis: a community-based study. Turk J Med Sci. 2016;46(2):303\u20139.","journal-title":"Turk J Med Sci"},{"issue":"4","key":"1288_CR33","doi-asserted-by":"publisher","first-page":"994","DOI":"10.5455\/medscience.2023.08.120","volume":"12","author":"F Etgu","year":"2023","unstructured":"Etgu F. Analysis of the epidemiology, coexisting skin diseases, and variables affecting seborrheic dermatitis severity. Med Sci Int Med J. 2023;12(4):994\u20137.","journal-title":"Med Sci Int Med J"},{"issue":"3","key":"1288_CR34","doi-asserted-by":"publisher","first-page":"362","DOI":"10.5472\/marumj.1195298","volume":"35","author":"E Sarac","year":"2022","unstructured":"Sarac E, Kocat\u00fcrk E. Relationship between disease severity, perceived stress, and depression in patients with seborrheic dermatitis. Marmara Med J. 2022;35(3):362\u20136.","journal-title":"Marmara Med J"},{"issue":"4","key":"1288_CR35","doi-asserted-by":"publisher","first-page":"327","DOI":"10.4103\/cdr.cdr_8_22","volume":"7","author":"N Goyal","year":"2023","unstructured":"Goyal N, Prabhu SS. Stress and common dermatological disorders: the psychophysiological dermatoses. Clin Dermatol Rev. 2023;7(4):327\u201332.","journal-title":"Clin Dermatol Rev"},{"key":"1288_CR36","doi-asserted-by":"crossref","unstructured":"Lancar R, Missy P, Dupuy A, et al. Risk factors for seborrhoeic dermatitis flares: case-control and case-crossover study. Acta Derm Venereol. 2020;100(17):adv00292.","DOI":"10.2340\/00015555-3661"},{"key":"1288_CR37","doi-asserted-by":"crossref","unstructured":"Andersen L, Nyeland ME, Nyberg F. Increasing severity of atopic dermatitis is associated with a negative impact on work productivity among adults with atopic dermatitis in France, Germany, the U.K. and the U.S.A. Br J Dermatol. 2020;182(4):1007\u201316.","DOI":"10.1111\/bjd.18296"},{"issue":"1","key":"1288_CR38","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jid.2016.07.012","volume":"137","author":"AM Drucker","year":"2017","unstructured":"Drucker AM, Wang AR, Li W-Q, Sevetson E, Block JK, Qureshi AA. The burden of atopic dermatitis: summary of a report for the National Eczema Association. J Invest Dermatol. 2017;137(1):26\u201330.","journal-title":"J Invest Dermatol"},{"issue":"3","key":"1288_CR39","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.jaad.2006.05.048","volume":"55","author":"DR Bickers","year":"2006","unstructured":"Bickers DR, Lim HW, Margolis D, et al. The burden of skin diseases: 2004 a joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology. J Am Acad Dermatol. 2006;55(3):490\u2013500.","journal-title":"J Am Acad Dermatol"},{"key":"1288_CR40","doi-asserted-by":"crossref","unstructured":"Peyr\u00ed J, Lleonart M, Grupo espa\u00f1ol del Estudio SEBDERM. Clinical and therapeutic profile and quality of life of patients with seborrheic dermatitis. Article in Spanish. Actas Dermosifiliogr. 2007;98(7):476\u201382.","DOI":"10.1016\/S1578-2190(07)70491-2"},{"issue":"1","key":"1288_CR41","doi-asserted-by":"publisher","DOI":"10.1111\/ina.12918","volume":"32","author":"J Wang","year":"2022","unstructured":"Wang J, Zhang Y, Li B, et al. Eczema, facial erythema, and seborrheic dermatitis symptoms among young adults in China in relation to ambient air pollution, climate, and home environment. Indoor Air. 2022;32(1):e12918.","journal-title":"Indoor Air"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-024-01288-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-024-01288-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-024-01288-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T03:16:54Z","timestamp":1731467814000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-024-01288-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,28]]},"references-count":41,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["1288"],"URL":"https:\/\/doi.org\/10.1007\/s13555-024-01288-9","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,28]]},"assertion":[{"value":"29 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Meredith T. Polaskey has no disclosures to report. Lakshi Aldredge, Candrice Heath,\u00a0Moises Acevedo, Matthew Zirwas, and Raj Chovatiya are investigators and\/or consultants for Arcutis Biotherapeutics, Inc. and received grants\/research funding and\/or honoraria. David H. Chu, Diane Hanna, and Melissa S. Seal are employees of Arcutis Biotherapeutics, Inc.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This study was supported by Arcutis Biotherapeutics, Inc. Thank you to the respondents for their participation in the surveys. Writing support was provided by Lauren Ramsey, PharmD of Alligent Biopharm Consulting LLC, and funded by Arcutis Biotherapeutics, Inc.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Medical Writing and Editorial Assistance"}},{"value":"The survey was not reviewed by an ethics committee and because of the nature of the survey and information collected is exempt from this requirement on the basis of the Human Subject Regulations Decision Charts: 2018 Requirements: 45 CFR 46.104(d)(2) for Educational Tests, Surveys, Interviews, or Observation of Public Behavior. The trial was conducted in accordance with the principles of the Declaration of Helsinki of 1964 and its later amendments and Good Clinical Practice guidelines of the International Council for Harmonisation. Not applicable: Before enrollment of patients, the study protocol and informed consent form were reviewed and approved by an appropriate institutional review board or independent ethics committee. Participants provided consent to participate in the survey and for the data to be published in aggregate.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}